Shafique Virani is Chief Business Officer of Recursion Pharmaceuticals, Inc.
Person profile
Roles
Recursion Pharmaceuticals
Chief Business Officer
Address
Salt Lake City, Utah
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
RECURSION PHARMACEUTICALS, INC.
18 Jan 24
144
RECURSION PHARMACEUTICALS, INC.
16 Jan 24
4
RECURSION PHARMACEUTICALS, INC.
19 Dec 23
144
RECURSION PHARMACEUTICALS, INC.
15 Dec 23
4
RECURSION PHARMACEUTICALS, INC.
17 Nov 23
144
RECURSION PHARMACEUTICALS, INC.
15 Nov 23
4
RECURSION PHARMACEUTICALS, INC.
18 Oct 23
144
RECURSION PHARMACEUTICALS, INC.
16 Oct 23
4
RECURSION PHARMACEUTICALS, INC.
19 Sep 23
144
RECURSION PHARMACEUTICALS, INC.
15 Sep 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jan 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Sell | Dispose S | No | Yes | 10.93 | 18,000 | 196.74 k | 136,748 |
16 Jan 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Option exercise | Acquire M | No | Yes | 2.22 | 18,000 | 39.96 k | 154,748 |
16 Jan 24 | RXRX Recursion Pharmaceuticals | Stock Option Class A Common Stock | Option exercise | Dispose M | No | Yes | 2.22 | 18,000 | 39.96 k | 361,469 |
15 Dec 23 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Sell | Dispose S | No | Yes | 9.6 | 18,000 | 172.80 k | 136,748 |
15 Dec 23 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Option exercise | Acquire M | No | Yes | 2.22 | 18,000 | 39.96 k | 154,748 |
15 Dec 23 | RXRX Recursion Pharmaceuticals | Stock Option Class A Common Stock | Option exercise | Dispose M | No | Yes | 2.22 | 18,000 | 39.96 k | 379,469 |
15 Nov 23 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Payment of exercise | Dispose F | No | No | 7.18 | 3,603 | 25.87 k | 136,748 |
15 Nov 23 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Sell | Dispose S | No | Yes | 6.51 | 18,000 | 117.18 k | 140,351 |
15 Nov 23 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Option exercise | Acquire M | No | Yes | 2.22 | 18,000 | 39.96 k | 158,351 |
15 Nov 23 | RXRX Recursion Pharmaceuticals | Stock Option Class A Common Stock | Option exercise | Dispose M | No | Yes | 2.22 | 18,000 | 39.96 k | 397,469 |